Collagen binding provides a sensitive screen for variant von Willebrand disease. - Wikidata - awgldk - TriplyDB

Collagen binding provides a sensitive screen for variant von Willebrand disease.

Collagen binding provides a sensitive screen for variant von Willebrand disease.

http://www.wikidata.org/entity/Q37367262

about

Diagnostic approach to von Willebrand disease Crucial role for the VWF A1 domain in binding to type IV collagen.Rapid discrimination of the phenotypic variants of von Willebrand disease.Microfluidic technology as an emerging clinical tool to evaluate thrombosis and hemostasis.Perils, problems, and progress in laboratory diagnosis of von Willebrand disease.An update on type 2B von Willebrand disease.Acquired von Willebrand syndrome in a child following Berlin Heart EXCOR Pediatric Ventricular Assist Device implantation: case report and concise literature review.Developments in the diagnostic procedures for von Willebrand disease.A diagnostic approach to mild bleeding disorders.Current and emerging approaches for assessing von Willebrand disease in 2016.Utility of the von Willebrand factor collagen binding assay in the diagnosis of von Willebrand disease.Clinical and laboratory phenotype variability in type 2M von Willebrand disease.A comparative evaluation of a new fully automated assay for von Willebrand factor collagen binding activity to an established method.Evaluation of a microfluidic flow assay to screen for von Willebrand disease and low von Willebrand factor levels.Comparison of an automated chemiluminescent assay to a manual ELISA assay for determination of von Willebrand Factor collagen binding activity on VWD plasma patients previously diagnosed through molecular analysis of VWF.Role of multimeric analysis of von Willebrand factor (VWF) in von Willebrand disease (VWD) diagnosis: Lessons from the PCM-EVW-ES Spanish project.

P2860

Q35220634-2DBECC6C-4200-4B8D-B3D7-ED22D5292A75 Q35252688-FCD68D01-A435-4503-B09A-BB272C219813 Q36920458-DE365491-7E98-45F3-9782-D0D7B03C1568 Q37012522-1894AFE0-49B1-411E-8B2A-F050DE723968 Q37703427-FB203887-3C9F-4EF4-9BB7-815F9FE6A7A6 Q38187477-8B3564B3-1ABD-4515-B8A2-B4902190D083 Q38260983-F03A78F3-25E1-4166-A7FF-B1C612361523 Q38682256-C75E03C1-9D1A-40FE-A915-D9B64B5A0CEE Q38840603-DDD253CA-ECAC-4145-A872-3769262A4B5D Q38900004-A017D24A-E588-48A9-BFFC-87F304CB4275 Q38953188-DAA17B09-3D2F-458A-A708-A03CB9F5A67D Q45868176-DA17F42C-27C3-46B3-A7A4-62A395EEF924 Q45874913-2740DF13-57C2-4EC9-AB67-3158088B7C7B Q47416217-E7189FFD-ECC3-4130-BE26-5341F6343C29 Q48239727-28EAF0C0-26B3-4D78-BEF7-72D9CD9C9ADF Q55431354-F84C2C7F-E592-45D1-A34D-3EA2EB28733B

P2860

Collagen binding provides a sensitive screen for variant von Willebrand disease.

http://www.wikidata.org/entity/Q37367262

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 22 January 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Collagen binding provides a sensitive screen for variant von Willebrand disease.

@en

Collagen binding provides a sensitive screen for variant von Willebrand disease.

@nl

type

label

Collagen binding provides a sensitive screen for variant von Willebrand disease.

@en

Collagen binding provides a sensitive screen for variant von Willebrand disease.

@nl

prefLabel

Collagen binding provides a sensitive screen for variant von Willebrand disease.

@en

Collagen binding provides a sensitive screen for variant von Willebrand disease.

@nl

P1433

Q37367262-0C1218C6-CE94-4388-96A5-75D575F7E12F

P1476

Q37367262-2970D57D-0825-4CD4-8484-15CB8058A94A

P2093

Q37367262-0D7159A2-6F53-4284-A1B9-BB440AD4E8A5

Q37367262-1830C5AE-9336-4033-B0B3-9F58B56A9496

Q37367262-1FD40A8F-118B-46F1-961E-370F0069FAF4

Q37367262-25833A4D-C293-45F6-B60B-A905B42013DF

Q37367262-45322C65-7A8F-41B2-B4D5-DF2DD7B88DD1

Q37367262-961991AA-BC70-49DD-B82A-A6EA0ABCF9EA

Q37367262-A3772D2F-5DFF-4B93-AADE-535B1C339742

Q37367262-A67CD767-8493-4D82-B7B0-CCB7353D7BD4

Q37367262-DD9B3060-9D0C-41E0-9F61-C6AB5837E36B

P2860

Q37367262-12EB0B67-A49B-4E28-BEDC-4022C42EACB9

Q37367262-1438C9FB-2C8D-43FA-912C-6B35B39C643F

Q37367262-174B6583-5681-4772-8B06-8BE7351AD60F

Q37367262-2E933113-3ECF-4839-B07D-F5075705846F

Q37367262-2F7C4916-EA5E-4B2B-89A8-810BD5F287F6

Q37367262-4CE2D216-2E89-4ECB-81EC-08AF6784C663

Q37367262-4EB085E7-388A-43D3-A5C6-37A7A7DF8669

Q37367262-672CE4E2-ECA0-4899-8035-260F5AE26A7A

Q37367262-93AE57AC-C38E-402A-A3E8-217C6940E414

Q37367262-9828AE9C-7217-49F8-9868-A17C30F81DD5

P304

Q37367262-0606A37A-C732-40E8-9F74-F626E19614C1

P31

Q37367262-942F6C20-5F6A-49E6-B37A-008D226CDD44

P356

Q37367262-032C983C-B8F2-4DED-9D2A-FD389D4C948D

P407

Q37367262-AD4CB0A2-A9C3-455C-9CDD-03245638A33A

P433

Q37367262-FBBC6BA5-CEAB-4656-8259-A9900888A621

P478

Q37367262-CCD333E3-8D61-44DC-9F2F-E5544A3B9DC2

P577

Q37367262-2EEE11DA-1D06-43A0-94CC-D6A45724375F

P698

Q37367262-3F1FDC1E-9233-46C9-87A8-003D5F2C841D

P932

Q37367262-2FD1AECD-B192-4517-8700-2C5B680B2B44

P356

CLINCHEM.2012.199000

P1433

Clinical Chemistry

P1476

Collagen binding provides a sensitive screen for variant von Willebrand disease.

@en

P2093

Joan Cox Gill

http://www.w3.org/2001/XMLSchema#string

Kenneth D Friedman

http://www.w3.org/2001/XMLSchema#string

Pamela A Christopherson

http://www.w3.org/2001/XMLSchema#string

Paula M Jacobi

http://www.w3.org/2001/XMLSchema#string

Raymond G Hoffmann

http://www.w3.org/2001/XMLSchema#string

Robert R Montgomery

http://www.w3.org/2001/XMLSchema#string

Sandra L Haberichter

http://www.w3.org/2001/XMLSchema#string

Veronica H Flood

http://www.w3.org/2001/XMLSchema#string

Zimmerman Program Investigators

http://www.w3.org/2001/XMLSchema#string

P2860

Critical von Willebrand factor A1 domain residues influence type VI collagen binding.

A novel candidate mutation (Arg611-->His) in type I 'platelet discordant' von Willebrand's disease with desmopressin-induced thrombocytopenia.

Acquired von Willebrand syndrome in aortic stenosis.

Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor.

Coating conditions matter to collagen matrix formation regarding von Willebrand factor and platelet binding.

Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit.

Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study.

VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population.

Regulated release of VWF and FVIII and the biologic implications.

Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.

P304

684-691

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1373/CLINCHEM.2012.199000

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23340442

http://www.w3.org/2001/XMLSchema#string

P932

3852672

http://www.w3.org/2001/XMLSchema#string